Top in cardiology: Preeclampsia and CVD risk in offspring; de novo postpartum hypertension
Click Here to Manage Email Alerts
Offspring of mothers with preeclampsia had an increased risk for ischemic heart disease and stroke compared with those not exposed to maternal preeclampsia, according to a recent study.
If the association is confirmed in future studies, researchers said the implementation of screening and primary prevention measures in offspring of mothers with preeclampsia may reduce the burden of CVD. It was the top story in cardiology last week.
The second top story was about the occurrence of de novo postpartum hypertension, which is estimated to affect one of 10 patients in the year following delivery.
“Monitoring during this period could mitigate severe postpartum and long-term cardiovascular complications,” Samantha Parker, PhD, an assistant professor of epidemiology at Boston University School of Public Health, said in a press release.
Read these and more top stories in cardiology below:
Offspring of mothers with preeclampsia have elevated risk for stroke, heart disease
In a Scandinavian cohort, offspring born to mothers with preeclampsia had elevated risk for ischemic heart disease and stroke, researchers reported in JAMA Network Open. Read more.
Limited postpartum follow-up may miss hypertension after delivery
Data from a large safety-net hospital show de novo postpartum hypertension occurs in one of 10 patients in the year after delivery, with nearly half from the delivery hospitalization, researchers reported. Read more.
Trial does not support routine antithrombotic use in ill outpatients with COVID-19
Routine antithrombotic use on top of usual care did not improve outcomes in high-risk, medically ill outpatients with SARS-CoV-2 infection vs. placebo, a speaker reported. Read more.
Remote BP, cholesterol management program may optimize guideline-directed therapy
An all-remote hypertension and hypercholesterolemia management program with more than 10,000 participants was associated with significant decreases in BP and LDL at 6 and 12 months compared with education only, researchers reported. Read more.
Self-administered nasal spray ‘rapidly’ treats paroxysmal supraventricular tachycardia
A fast-acting nasal spray safely and effectively converted episodes of paroxysmal supraventricular tachycardia to normal sinus rhythm with a significant reduction in ED utilization and medical intervention, researchers reported. Read more.